Skip to main content
Clinical Trials/NCT01783327
NCT01783327
Completed
N/A

Teens-Connect: Preventive Psycho-education for Transitioning Teens With Diabetes

Yale University2 sites in 1 country124 target enrollmentJuly 2012

Overview

Phase
N/A
Intervention
Not specified
Conditions
Diabetes Mellitus, Type 1
Sponsor
Yale University
Enrollment
124
Locations
2
Primary Endpoint
Change from baseline hemoglobin A1c over 12 months
Status
Completed
Last Updated
10 years ago

Overview

Brief Summary

The purpose of this study is to evaluate the use of a state-of the art internet psycho-educational program in clinical practice (Teens-Connect), compared to use of a standard and widely available internet diabetes program for youth (Planet D™) in a mixed-method randomized clinical trial design.

Detailed Description

The aims are: 1. To evaluate the efficacy and cost-effectiveness of provider-prescribed Teens-Connect (TEENCOPE™+Managing Diabetes) in pediatric diabetes practice compared to prescription of Planet D™. The hypotheses to be studied are: 1. Youth who participate in Teens-Connect will have better metabolic control (A1c) and quality of life (QOL) than those who participate in Planet D. 2. These effects will be mediated by improvements in stress/coping, self-efficacy, diabetes problem-solving, and self-management. 3. Teens-Connect prescribed by providers in diabetes clinics will be a cost-effective approach to reduce A1c and improve quality-adjusted life years (QALYs) for youth with T1D. 2. To compare the reach, efficacy, adoption, implementation, and maintenance (RE-AIM) of the two provider-prescribed psycho-educational internet programs.

Registry
clinicaltrials.gov
Start Date
July 2012
End Date
August 2015
Last Updated
10 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Diagnosed with type 1 diabetes for at least 6 months
  • Age 11 to 14 years
  • English-speaking
  • Parent/guardian consent to participate in study

Exclusion Criteria

  • \*Previous exposure to TEENCOPE and/or Managing Diabetes

Outcomes

Primary Outcomes

Change from baseline hemoglobin A1c over 12 months

Time Frame: Baseline, 6 weeks, 6 months, 12 months

Change from baseline quality of life over 12 months

Time Frame: Baseline, 6 weeks, 6 months, 12 months

Secondary Outcomes

  • Change from baseline coping/Stress over 12 months(Baseline, 6 weeks, 6 months, 12 months)
  • Change from baseline quality adjusted life years over 12 months(Baseline, 6 weeks, 6 months, 12 months)
  • Change from baseline problem-solving over 12 months(Baseline, 6 weeks, 6 months, 12 months)
  • Change from baseline self-efficacy over 12 months(Baseline, 6 weeks, 6 months, 12 months)
  • Change from baseline self-management over 12 months(Baseline, 6 weeks, 6 months, 12 months)
  • Costs(6 months)

Study Sites (2)

Loading locations...

Similar Trials